Jahreskongress
Congrès Annuel
Annual Meeting
Lausanne
Swiss Tech Convention Center
14.-15.September 2017
Menu
Programme
Thursday, 14.9.2017
| 0830-1000 SALLE 3 | IBD Session (sponsored by MSD) Gerhard Rogler, Zürich Stephan Brand, St. Gallen |
| 0830-0900 SALLE 3 | Integrating nutritional approaches in IBD management Herbert Tilg, Innsbruck |
| 0900-0930 SALLE 3 | Diagnosing intestinal Crohn's Disease Luc Biedermann, Zürich |
| 0930-1000 SALLE 3 | Management of IBD in 2017 Peter Lakatos, Montreal |
| 0830-1000 SALLE 4 | State of the Art Upper GI Surgery Diego De Lorenzi, Grabs Raphael Meier, Genève |
| 0830-0900 SALLE 4 | GERD and Hiatal Hernia Urs Zingg, Schlieren |
| 0900-0930 SALLE 4 | Esophageal Tumors Christian A. Seiler, Bern |
| 0930-1000 SALLE 4 | Tumors of the EGJ and Stomach Markus Schäfer, Lausanne |
| 1000-1030 Foyer Garden (exhibition) | Coffee break |
| 1030-1200 SALLE 3 | Joint SGG-SGVC Upper GI Session (sponsored by Takeda Pharma) Radu Tutuian, Bern Markus K. Müller, Frauenfeld |
| 1030-1100 SALLE 3 | Esophageal motility disorders: update 2017 Mark Fox, Basel |
| 1100-1130 SALLE 3 | Controversies in the management of gastroesophageal reflux disease Jan Borovicka, St.Gallen |
| 1130-1200 SALLE 3 | Obesity surgery Diana Vetter, Zürich |
| 1200-1230 Foyer Garden (exhibition) | Lunch break |
| 1230-1330 SALLE 5 | Lunch Symposium AbbVie: Preventing Disease Progression in IBD – Do we have a Target to Treat? Alain Schoepfer, Lausanne Gerhard Rogler, Zürich Shomron Ben-Horin, Tel Aviv |
| 1230-1330 SALLE 3 | Lunch Symposium Takeda Pharma AG: 2 years of Entyvio® in Swiss clinical practice – what are the learnings? Luc Biedermann, Zürich Pierre Michetti, Lausanne |
| 1330-1500 SALLE 3 | SIBDCS and Free Communications Michel Maillard, Lausanne Stephan R. Vavricka, Zürich |
| 1330-1400 SALLE 3 | The Swiss IBD Cohort Study: current status and perspectives Gerhard Rogler, Zürich |
| 1400-1410 SALLE 3 | Efficacy and safety of budesonide orodispersible tablets in active eosinophilic oesophagitis: Results from a randomised, double-blind, placebo-controlled, pivotal, European multicentre trial (EOS-1) Alex Straumann, Olten |
| 1410-1420 SALLE 3 | The Stimulation of Macrophages with Microbial-Derived Compounds Supports Increased IL-19 Expression in Colitis Jan Niess, Basel |
| 1420-1430 SALLE 3 | Gut Microbial Changes in Inflammatory Bowel Disease Patients in Response to Biologic Therapy Bahtiyar Yilmaz, Bern |
| 1430-1440 SALLE 3 | Impact of diagnostic delay in pediatric Crohn’s disease patients compared to adult patients Jessica Santos, Lausanne |
| 1440-1450 SALLE 3 | Systematic Analysis of Annual Health-care Costs in Hospitalized Inflammatory Bowel Disease Patients in Switzerland Alain Schoepfer, Lausanne |
| 1330-1500 SALLE 5 | Autoimmune Liver Disease and Free Communications Beat Müllhaupt, Zürich Andrea De Gottardi, Bern |
| 1330-1400 SALLE 5 | Autoimmune liver disease Gideon Hirschfield, Birmingham |
| 1400-1410 SALLE 5 | Autologous differentiation of liver derived iPSC into hepatocyte-like cells Diego Calabrese, Basel |
| 1410-1420 SALLE 5 | Gallbladder Derived Stem Cells: A New Chance for Cell Therapy in the Liver Felix Baier, Bern |
| 1420-1430 SALLE 5 | Palmitoylation Determines the Subcellular Localization of Hepatitis E Virus ORF3 Protein Jérôme Gouttenoire, Lausanne |
| 1430-1440 SALLE 5 | Discontinuation of immunosuppression in immune mediated drug induced liver injury (IM-DILI) : a case control study Laurent Spahr, Geneva |
| 1440-1450 SALLE 5 | Increasing Imports of Direct-Acting Antivirals (DAAs) via FixHepC Buyers Club and Medical Tourism by Swiss Patients with Chronic Hepatitis C Infection David Semela, St. Gallen |
| 1330-1500 SALLE 4 | HIPEC for GI Cancers and SGVC Free Communications Antonio Nocito, Baden Guido Beldi, Bern |
| 1330-1400 SALLE 4 | HIPEC for GI Cancers - current indications Beate Rau, Berlin |
| 1400-1410 SALLE 4 | Coffee accelerates recovery of bowel function after elective colon resection – a randomized controlled trial Simone Hasler, Baden |
| 1410-1420 SALLE 4 | Surgical site infections after pancreatic surgery in the era of enhanced recovery protocols Gaëtan-Romain Joliat, Lausanne |
| 1420-1430 SALLE 4 | Lymph node yield during pancreatic surgery - a distinct view Mathias Worni, Bern |
| 1430-1440 SALLE 4 | Exosomal biomarkers to diagnose and monitor pancreatic ductal adenocarcinoma Michel Dosch, Bern |
| 1440-1450 SALLE 4 | Impact of venous invasion on short- and long-term outcomes after distal pancreatectomy for cancer Gaëtan-Romain Joliat, Lausanne |
| 1500-1530 Foyer Garden (exhibition) | Coffee break |
| 1530-1700 SALLE 3 | Colorectal Neoplasms Jan Borovicka, St.Gallen Lukas Degen, Basel |
| 1530-1600 SALLE 3 | Current management of hereditary colon cancer syndromes Karl Heinimann, Basel |
| 1600-1630 SALLE 3 | How dangerous are serrated adenomas? Evelien Dekker, Amsterdam |
| 1630-1700 SALLE 3 | Initial experience with Vaud CRC screening program Gian Dorta, Lausanne |
| 1530-1700 SALLE 5 | Hemochromatosis and Free Communications Pierre Deltenre, Lausanne Andreas Cerny, Lugano |
| 1530-1600 SALLE 5 | What's new in hemochromatosis? Heinz Zoller, Innsbruck |
| 1600-1610 SALLE 5 | A Functional Insertion Screen for Hepatitis E Virus Dagmara Szkolnicka, Lausanne |
| 1610-1620 SALLE 5 | Intestinal microbiota significantly alters hepatic expression of energy metabolism genes in mice with acute cholestasis Sheida Moghadamrad, Bern |
| 1620-1630 SALLE 5 | Hepatocyte transporter expression in chronic liver disease: correlation with fibrosis severity and dynamic gadoxetic acid-enhanced (Gd-EOB-DTPA) MRI findings Amedeo Sciarra, Lausanne |
| 1630-1640 SALLE 5 | Evaluation of Controlled Attenuated Parameter (CAP) for Assessment of Liver Steatosis in an Unselected Population: a Single Center Real Life Experience Stephan Baumeler, St. Gallen |
| 1640-1650 SALLE 5 | The Swiss HCV Advisor App - A web-based mobile application to identify suitable treatments with direct antiviral agents for chronic hepatitis C virus infection Heiko Frühauf, Zürich |
| 1530-1700 SALLE 4 | SGVC: What's in the spotlight in ... Nicolas Demartines, Lausanne Frédéric Triponez, Genève |
| 1530-1550 SALLE 4 | Endocrine Surgery Daniel Oertli, Basel |
| 1550-1610 SALLE 4 | HBP Surgery Daniel Candinas, Bern |
| 1610-1640 SALLE 4 | Colorectal surgery Christianne Buskens, Amsterdam |
| 1640-1700 SALLE 4 | Parieteology René Vonlanthen, Zürich |
| 1715-1815 SALLE 3 | General Assembly SGG |
| 1815-1900 SALLE 3 | General Assembly SASL |
| 1815-1900 SALLE 5 | General Assembly MDL |
| 1815-1900 SALLE 4 | General Assembly IBDnet |
Friday, 15.9.2017
| 0730-0815 SALLE 5 | Early Bird Symposium Janssen-Cilag: Cytokine therapy in IBD beyond TNFs Gerhard Rogler, Zürich Pierre Michetti, Lausanne |
| 0830-1000 SALLE 3 | Celiac Disease and Free Communications Michel Maillard, Lausanne Dominique Henri Criblez, Luzern |
| 0830-0900 SALLE 3 | Celiac Disease Christophe Cellier, Paris |
| 0900-0910 SALLE 3 | Long-term treatment of eosinophilic esophagitis with swallowed topical corticosteroids: development and evaluation of a therapeutic concept Thomas Greuter, Zürich |
| 0910-0920 SALLE 3 | Nlrp6 expression in activated CD4 T cells is independent of intestinal microbiota Jan Niess, Basel |
| 0920-0930 SALLE 3 | Disincentive and motivating factors for colorectal cancer screening in the Swiss population Nora Brunner-Schaub, Zürich |
| 0930-0940 SALLE 3 | Performance comparison of full-spectrum versus forward-viewing colonscopy: a randomized controlled tria Martin Geyer, Wettingen |
| 0940-0950 SALLE 3 | Efficacy and safety of linaclotide in the treatment of IBS-C from a real-world observational Swiss study Daniel Pohl, Zürich |
| 0830-1000 SALLE 5 | SASL Hot Topics in Liver Disease (sponsered by Intercept Pharma) David Semela, St. Gallen Jean-François Dufour, Bern |
| 0830-0900 SALLE 5 | The Swiss Hepatitis C Cohort Study: current status and perspectives Francesco Negro, Geneva |
| 0900-0930 SALLE 5 | Exploring new frontiers in hepatitis B Beat Müllhaupt, Zürich |
| 0930-1000 SALLE 5 | Advances in liver cell adenoma Christine Sempoux, Lausanne |
| 0830-1000 SALLE 4 | Surgery Video Session: My way of doing a ... Franc Hetzer, Uznach Ralph Peterli, Basel |
| 0830-0855 SALLE 4 | Total Thyroidectomy with LAD Frédéric Triponez, Genève |
| 0855-0920 SALLE 4 | Laparoscopic Fundoplication Christian A. Gutschow, Zürich |
| 0920-0940 SALLE 4 | Laparoscopic Left Hemicolectomy Dieter Hahnloser, Lausanne |
| 0940-1000 SALLE 4 | Laparoscopic Distal Pancreatectomy Jörg Wydler, Zürich |
| 1000-1030 Foyer Garden (exhibition) | Coffee break |
| 1030-1200 SALLE 3 | SGG-SGVC-SASL Prize Winners and Best Abstracts Session Darius Moradpour, Lausanne Peter Bauerfeind, Zürich Daniel Oertli, Basel |
| 1030-1040 SALLE 3 | Prize Winner Gastroenterology |
| 1040-1050 SALLE 3 | Prize Winner Hepatology |
| 1050-1100 SALLE 3 | Prize Winner Surgery |
| 1100-1110 SALLE 3 | Best Abstract Gastroenterology |
| 1110-1120 SALLE 3 | Best Abstract Hepatology |
| 1120-1130 SALLE 3 | Best Abstract Surgery |
| 1130-1200 Foyer Garden (exhibition) | Guided Poster Tours |
| 1200-1230 Foyer Garden (exhibition) | Lunch break |
| 1230-1330 SALLE 3 | Lunch Symposium AbbVie: A Pan-Genotypic Future: Do we finally have the tools to eliminate HCV? David Semela, St. Gallen Nasser Semmo, Bern Philip Bruggmann, Zürich Stanislas Pol, Paris |
| 1230-1330 SALLE 5 | Lunch Symposium Vifor: IBD: Sex, Drugs and… Gerhard Rogler, Zürich Stephan R. Vavricka, Zürich Pierre Michetti, Lausanne Christian Rollini, Lausanne |
| 1330-1500 SALLE 3 | Advances in GI Endoscopy (sponsered by Olympus) Michael Fried, Zürich Jean-Louis Frossard, Geneva |
| 1330-1400 SALLE 3 | Management of achalasia: choices in 2017 Guy E. Boeckxstaens, Leuven |
| 1400-1430 SALLE 3 | What do I do with cystic lesions of the pancreas? Rainer Schöfl, Linz |
| 1430-1440 SALLE 3 | Video: Treatment of esophageal perforation by Eso-sponge®: first year experience in a Swiss university center Michael Drepper, Geneva |
| 1440-1450 SALLE 3 | Video: Endoscopic removal of foreign bodies Stephan Baumeler, St. Gallen |
| 1450-1500 SALLE 3 | Video: Transoral outlet reduction (TORe) partially reverses weight regain after bariatric Roux-en-Y gastric bypass (RYGB). First clinical experience from a tertiary referral center Patrick Aepli, Luzern |
| 1330-1500 SALLE 5 | NRH and Free Communications Joachim Mertens, Zürich Francesco Negro, Geneva |
| 1330-1400 SALLE 5 | Nodular regenerative hyperplasia David Semela, St. Gallen |
| 1400-1410 SALLE 5 | Can treatment of activated fibroblasts at the level of fibrosis reduce the development of liver cancers? Joachim Mertens, Zürich |
| 1410-1420 SALLE 5 | Changes in circulating osteopontin and relationship with serial liver biopsies in the course of alcoholic hepatitis Laurent Spahr, Geneva |
| 1420-1430 SALLE 5 | Nurse-led self-management support in liver transplantation across two hospitals Patrizia Künzler, St. Gallen |
| 1430-1440 SALLE 5 | Combined Liver and Lung Transplantation in Geneva University Hospital Laure Elkrief, Geneva |
| 1440-1450 SALLE 5 | Propofol sedation in routine endoscopy: case series comparing target controlled infusion vs. nurse administered bolus-concept Riad Sarraj, Bern |
| 1500-1530 Foyer Garden (exhibition) | Coffee break |
| 1530-1700 SALLE 3 | EoE and Clinical/Video Cases Alain Schoepfer, Lausanne Christoph Gubler, Winterthur |
| 1530-1600 SALLE 3 | Eosinophilic esophagitis: achievements and challenges Alex Straumann, Olten |
| 1600-1610 SALLE 3 | Late Hepatitis B Reactivation Following DAA-Based Treatment of Recurrent Hepatitis C in an anti-HBc-Positive Liver Transplant Recipient Julien Vionnet, Lausanne |
| 1610-1620 SALLE 3 | Case report: Resection of a large circumferential rectal adenoma with a novel resection system (EndoRotor) Patrick Aepli, Luzern |
| 1620-1630 SALLE 3 | Bariatric surgery in patients with hemochromatosis: advantage for proximal gastric bypass over sleeve gastrectomy? Urs Pfefferkorn, Olten |
| 1630-1640 SALLE 3 | Use of a Novel Ultrasonic Vascular Imaging Technique for the Diagnosis of Focal Nodular Hyperplasia in the Liver - Case Series Mikael Sawatzki, St. Gallen |
| 1640-1650 SALLE 3 | Successful performance of a laparoscopic Pancreatico-duodenectomy (Whipple/Kausch) procedure Erik Schadde, Zürich |
| 1650-1700 SALLE 3 | Cholangioscopy of bile duct stenosis: Stone or tumor? Reto Bertolini, Winterthur |
Posters
Gastroenterology
| G1 | Treatment Satisfaction of Adult Eosinophilic Esophagitis Patients Ekaterina Safroneeva (1), David Hafner (1), Claudia Kuehni (1), Marcel Zwahlen (1), Sven Trelle (1), Alex Straumann (2), Alain Schoepfer (3) 1 Institute of Social and Preventive Medicine, University of Bern, Switzerland 2 Swiss EoE Clinic Switzerland, Olten 3 Division of Gastroenterology and Hepatology, CHUV, Lausanne | |
| G2 | Systematic Analysis of Subepithelial Eosinophil Counts Increases Diagnostic Yield in Adults With Eosinophilic Esophagitis Alain Schoepfer (1), Audrey Simko (1), Christian Bussmann (2), Ekaterina Safroneeva (3), Marcel Zwahlen (3), Sebastien Godat (1), Hugo Maye (1), Alex Straumann (4) 1 CHUV, Lausanne; 2 Viollier Pathology, Basel; 3 ISPM, Bern; 4 University Hospital Zurich. | |
| G3 | Endoscopic full thickness resection (EFTR) of colorectal neoplasms with the “Full Thickness Resection Device” (FTRD): Clinical experience from two tertiary referral
centers in Switzerland. Patrick Aepli (1), Dominique Criblez (1), Stephan Baumeler (2), Jan Borovicka (2), Remus Frei (2) 1 Gastroenterology Unit, Luzerner Kantonsspital, Lucerne 2 Division of Gastroenterology/Hepatology, Kantonsspital St. Gallen, St. Gallen | |
| G4 | Double-balloon enteroscopy-assisted dilatation avoids surgery in majority of patients with small bowel strictures: a systematic review. Judith Baars (1), Ruben Theyventhiran (1), Patrick Aepli (2), Payal Saxena (1), Arthur Kaffes (1) 1 AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, Australia 2 Gastroenterology Unit, Luzerner Kantonsspital, Lucerne, Switzerland | |
| G5 | Multicentre European Evaluation Of A Novel Technology (Blue Light Imaging) In The Diagnosis Of Small Colorectal Polyps Sharmila Subramaniam (1), Patrick Aepli (2), Gabriele Wurm Johansson (3), Erik Schoon (4), Milan Stefanovic (5), Pradeep Bhandari (1) 1 Department of Gastroenterology, Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom 2 Gastroenterology Unit, Luzerner Kantonsspital, Lucerne, Switzerland 3 Department of Clinical Sciences, Skane University Hospital, Malmo, Sweden 4 Department of Gastroenterology, Catharina Hospital, Eindhoven, Netherlands 5 Gastroenterology, Diagnostic Center Bled, Ljubljana, Slovenia | |
| G6 | Development of a Conditional Mouse Line to Study Nutritional Requirements of Monocytes and Macrophages Philipp Wuggenig, Anna Steinert, Katarina Radulovic, Berna Kaya, Petr Hruz, Jan Hendrik Niess Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland, Division of Gastroenterology and Hepatology, University Hospital Basel, University of Basel, Switzerland | |
| G7 | Mucosal Dendritic Cells and Macrophages Express the G Protein Coupled Receptor 35 Berna Kaya, Philipp Wuggenig, Katarina Radulovic, Anna Steinert, Petr Hruz, Jan Hendrik Niess Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland, Division of Gastroenterology and Hepatology, University Hospital Basel, University of Basel, Switzerland | |
| G8 | Treatment of a perforated cholecystitis into a congenital liver cyst with EUS-guided liver abscess drainage Ioannis Kapoglou 1, Reiner Wiest 1, Johannes Maubach 1 Gastroenterology, Clinic for Visceral Surgery and Medicine, University Hospital of Bern | |
| G9 | Clinical characteristics and treatment outcome of Eosinophilic Gastroenteritis: Analysis of the Swiss Database SEED Tanja Grandinetti (1), Luc Biedermann (2), Petr Hruz (3), Alex Straumann (4) 1) Division of Internal Medicine, University Hospital Basel, Switzerland 2) Division of Gastroenterology & Hepatology, University Hospital Zurich, Switzerland 3) Division of Gastroenterology & Hepatology, University Hospital Basel, Switzerland 4) Swiss EoE Clinic and Swiss EoE Research Network Olten, Switzerland | |
| G10 | Proximally migrated pancreatic stent extraction assisted by endosonographic-guided pancreaticogastrostomy Benjamin Heimgartner (1), Johannes Maubach (1), Reiner Wiest (1) 1 University Clinic for Visceral Surgery and Medicine, Division of Gastroenterology, University of Berne | |
| G11 | An unusual cause of severe reccurent gastroenteritis Sara Stadelmann(1), Isabelle Pache(1), Nathalie Pasquier (2), Tarek Laswad(1), Marc Uhlmann(1) 1)Hôpital Riviera-Chablais, Monthey, 2) Institut Central des Hôpitaux Sion, Sion | |
| G12 | Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS) Alain Schoepfer (1), Catherine Saner (2), Ekaterina Safroneeva (3), Petr Hruz (4), Patrick Aepli (5), Mikael Sawatzki (6), Stephan Vavricka (7), Luc Biedermann (7), Pascal Juillerat (8), Alex Straumann (7); SEECS group 1 CHUV, 2 IUMSP Lausanne, 3 ISPM Bern, 4 University hospital Basel, 5 Kantonsspital Luzern, 6 Kantonsspital St. Gallen, 7 University hospital Zurich, 8 Inselspital, Bern. | |
| G13 | Adenoma Detection Rates in Colonoscopies at the University Hospital of Basel in 2015 Manuel Sutter, Petr Hruz, Lukas Degen, Jan Hendrik Niess Department of Gastroenterology and Hepatology, University Hospital of Basel, University of Basel, Basel, Switzerland | |
| G14 | Effectiveness of Vedolizumab Induction Therapy in IBD Patients Tanay Kaymak, Jan H. Niess, Petr Hruz Department of Gastroenterology & Hepatology, University Hospital Basel, Switzerland | |
| G15 | Endoskopische Behandlung von akuten Blutungen mit einem Over-The-Scope Clip (OTSC) Alexander Braun, Sarah Peter Gastroenterologie, SRO Langenthal, Langenthal | |
| G16 | Effects of cervical transcutaneous electrical vagus nerve stimulation on esophageal contractility: A pilot trial Simone Srivastava (1), Ioannis Linas (1), Johannes Lenglinger (1), Radu Tutuian (2), Reiner Wiest (1) (1) Dept. of Visceral Surgery & Medicine, Inselspital, (2) Dept. of Gastroenterology, Tiefenau-Spital, University of Bern, Bern | |
| G17 | Long term effects after sphincterotomy in patients with suspected functional sphincter disorder: role of Nardi-Test Vasileios Oikonomou1, Martin Maurer2, Johannes Heverhagen2, Andrew Macpherson1, Reiner Wiest1 1. Gastroenterology, Clinic for Visceral Surgery and Medicine, University Hospital of Bern, 2. Department of Radiology, University Hospital of Bern. | |
| G18 | Non-invasive and semi-invasive methods for the diagnosis and clinical surveillance of Eosinophilic Esophagitis (EoE) Johanna Gückel (1), Michael Schneider (2), Jakob Weber (2) , Alex Straumann (3), Petr Hruz (1) (1)Department of Gastroenterology and Hepatology, University Hospital Basel, Switzerland (2)Bühlmann Laboratories, Schönenbuch, Switzerland (3)EoE Clinic, Praxis Römerhof, Olten, Switzerland | |
| G19 | Impedance planimetry (EndoFLIP®) at the esophago-gastric junction distinguishes neuromuscular disorders from fibrotic lesions in dysphagia patients. Johannes Lenglinger(1), Monica Rusticeanu(1), Benjamin Heimgartner (1), Radu Tutuian(2), Reiner Wiest(1) (1)Dept. of Visceral Surgery and Medicine, Inselspital, (2)Tiefenau-Spital, University of Bern, Bern | |
| G20 | Endoscopic removal of intrahepatic intraductal papillary neoplasm of the left biliary duct (IPNB) via endoscopic ultra-sound-based gastro-hepaticostomy (EUS-HGS) Johannes Maubach1, Benjamin Heimgartner1, Reiner Wiest1 Department of Visceral Surgery and Medicine1, Bern University Hospital Inselspital, Bern, Switzerland | |
| G21 | Caught on camera: yellow jacket found incidentally during colonoscopy B.Friedli1, P.Juillerat1, A.Frenzer2 1. Department of gastroenterology Inselspital Berne 2. Department of gastroenterology Spital Thun | |
| G22 | Radiologic, Endoscopic and Functional Patterns in Patients with Symptomatic Gastroesophageal Reflux Disease after Roux-en-Y Gastric Bypass Y.Borbély, Ph.Nett, D.Kröll, R.Tutuian, J.Lenglinger Clinic for Visceral Surgery and Medicine, University Hospital, Inselspital Bern | |
| G23 | Vitamin D status in patients with Inflammatory Bowel Disease in comparison to controls: a cross sectional study Daniel Caviezel (1), Silvia Maissen (2), Jan Hendrik Niess (1), Caroline Kiss (2), Petr Hruz (1) (1) Department of Gastroenterology and Hepatology, University Hospital of Basel, Switzerland (2) Dietetic Service; Endokcrinology, Diabetology & Metabolism, University Hospital of Basel, Switzerland | |
| G24 | Endoscopic submucosal dissection and endoscopic mucosal resection for treatment of high grade dysplasia and adenocarcinoma in Barrett’s esophagus : a case series. Stefano Guglielmi(1), Philippe Bichard(1), Michael Drepper(1), Vincent Lepilliez(1), Stefan Mönig(2), Jean-Louis Frossard(1); (1)Division of Gastroenterology and Hepatology, (2)Division of Visceral Surgery, Geneva University Hospital, Geneva Service de Gastroentérologie et Hépatologie des Hôpitaux Universitaires de Genève. | |
| G25 | Comparison of two bowel preparations for colonoscopy Moviprep and Citrafleet in daily practice Martin Geyer, Gastroenterologie Wettingen, Dominik Leiner, Ludwig-Maximilians University Munich, Germany Gastroenterologie Wettingen | |
| G26 | Lumen-Apposing Metal Stents for Drainage of Pancreatic Fluid Collections: Experience From Two Non-University Centers in Switzerland Remus Frei (1), Jan Borovicka (1), Thomas Greuter (2), Daniel M. Frey (3), Bernhard Magdeburg2 (1) Division of Gastroenterology and Hepatology, Kantonsspital St. Gallen, St. Gallen, Switzerland, (2) Department of Internal Medicine, GZO – Zurich Regional Health Center, Wetzikon, Switzerland, (3) Department of Surgery, GZO – Zurich Regional Health Center, Wetzikon, Switzerland | |
Hepatology
| H1 | Safety of glecaprevir/pibrentasvir in adults with chronic genotype 1-6 hepatitis C virus infection: an integrated analysis Jean-Francois Dufour*1, Eli Zuckerman2, Neddie Zadeikis3, Christophe Hezode4, Seung Woon Paik5,Pietro Andreone6, Ola Weiland7, Jihad Slim8, Steven L. Flamm9, Timothy Morgan10, Hugo Vargas11,Simone Strasser12, Ashley Brown13, Yao Yu3, Ariel Porcalla3, Fede 1University Clinic for Visceral Surgery and Medicine, Inselspital, Bern, Switzerland, 2Carmel Medical Center Liver Institute, Haifa, Israel, 3AbbVie, North Chicago, IL, United States, 4Hôpital Henri Mondor, Université Paris-Est, Créteil, France, 5Samsung Medical Center, Seoul, Korea, South, 6Dipartimento di Scienze Mediche e Chirurgiche, University of Bologna, Bolongna, Italy, 7Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden, 8St. Michael’s Medical Center, Newark, NJ, 9Northwestern Feinberg School of Medicine, Chicago, IL, 10Veteran’s Affairs Long Beach Healthcare System, Long Beach, CA, 11Mayo Clinic, Phoenix, AZ, United States, 12Royal Prince Alfred Hospital, Sydney,Australia, 13Imperial College Healthcare, London, United Kingdom. | |
| H2 | High SVR Rates with Eight and Twelve Weeks of Pangenotypic
Glecaprevir/Pibrentasvir: Integrated Efficacy and Safety Analysis of Genotype 1-6 Patients without Cirrhosis Massimo Puoti*1, Graham Foster2, Stanley Wang3, David Mutimer4, Edward Gane5, Christophe Moreno6, Ting Tsung Chang7, Sam S. Lee8, Rui Marinho9, Jean-Francois Dufour10, Stanislas Pol11, Christophe Hezode12, Stuart C. Gordon13, Simone I. Strasser14, Paul J. 1AO Ospedale Niguarda Ca Granda, Milan, Italy, 2Queen Mary University of London, Barts Health, London, United Kingdom, 3ABBVIE, North Chicago, United States, 4Queen Elizabeth Hospital and NIHR Liver Biomedical Research Unit, Birmingham, United Kingdom, 5University of Auckland, Auckland, New Zealand, 6CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium, 7National Cheng Kung University Hospital, Tainan City, Taiwan, 8University of Calgary, Calgary, Canada, 9Hospital S. Maria, Medical School of Lisbon, Lisbon, Portugal, 10Hepatology, University clinic for visceral surgery and medicine, Bern University Hospital, Bern, Switzerland, 11Groupe Hospitalier Cochin-Saint Vincent De Paul, Paris, 12Hôpital Henri Mondor, AP-HP, Université Paris-Est, Créteil, France, 13Henry Ford Health System, Detriot, United States, 14Royal Prince Alfred Hospital, Sydney, Australia, 15Mercy Medical Center & University of Maryland School of Medicine, Baltimore, United States | |
| H3 | OCA Treatment in Patients with PBC and Cirrhosis John M. Vierling(1), Gideon M. Hirschfield(2), Leigh MacConell(3) (1) Baylor College of Medicine, Houston, TX, US; (2) University of Birmingham, Birmingham, UK; (3) Intercept Pharmaceuticals, Inc., San Diego, CA, US | |
| H4 | FXR/TGR5 Dual Agonist INT-767 Reduces NAS & Fibrosis & Improves Plasma & Hepatic Lipid Profiles in the AMLN Mouse Model of Diet-induced & Biopsy-confirmed NASH Jonathan Roth(1), Michael Feigh(2), Sibylle Herrmann(3) (1)Intercept Pharmaceuticals, Inc., San Diego, US; (2)Gubra, Hørsholm, Denmark; (3)Intercept Pharma Europe, London, UK | |
| H5 | Investigating the Role of CD151 and CD63 in the Hepatitis E Virus Life Cycle Noémie Oechslin, Angela Pollán, Darius Moradpour and Jérôme Gouttenoire Division of Gastroenterology and Hepatology, CHUV, University of Lausanne, CH-1011 Lausanne | |
| H6 | Comparison of human NAFLD and animal models using hepatic whole-genome transcriptomic meta-analysis Nicolas Goossens (1), Laurent Spahr (1), Petros Tsantoulis (2, 3), Jean-Louis Frossard (1), Yujin Hoshida (4), Francesco Negro (1,5) Affiliations: (1) Gastroenterology and Hepatology, Geneva University Hospital, Geneva, Switzerland. (2) Division of Oncology, Geneva University Hospital, Geneva, Switzerland. (3) Bioinformatics Core Facility, Swiss Institute of Bioinformatics (4) Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, USA (5) Division of Pathology, University Hospital, 1205 Geneva, Switzerland | |
| H7 | Epidemiology and Treatment of Hepatitis C Virus Infection
in a Hospital-Based Population in Eastern Switzerland Urs Rusch(1), Patrizia Künzler(1), Pietro Vernazza(2), Sarah Blach(3), Homie Razavi(3), David Semela(1) (1) Division of Gastroenterology and Hepatology, Kantonsspital St.Gallen, St.Gallen. (2) Division of Infectious Diseases, Kantonsspital St.Gallen, St.Gallen (3) Center for Disease Analysis, Louisville (CO) USA. | |
| H8 | How to Eliminate Hepatitis C in Eastern Switzerland –
A Model-Based Scenario Urs Rusch (1), Patrizia Künzler (1), Pietro Vernazza (2), Sarah Blach (3), Homie Razavi (3), David Semela (1). (1) Division of Gastroenterology and Hepatology, Kantonsspital St.Gallen, St.Gallen. (2) Division of Infectious Diseases, Kantonsspital St.Gallen, St.Gallen. (3) Center for Disease Analysis, Louisville (CO) USA. | |
Surgery
| S1 | Verteporfin potentiates the anti-tumor effect of Sorafenib by inhibiting hepatocellular carcinoma progression through interfering with the autophagic flux J. Gavini, N. Dommann, D. Candinas, D. Stroka , V. Banz Department for Visceral Surgery and Medicine, Bern University Hospital, University of Bern, Bern, Switzerland | |
| S2 | The impact of preoperative investigations on the management of bariatric patients; results of a cohort of more than 1200 cases Romano Schneider (1), Ioannis Lazaridis (1), Marko Kraljevic (1) , Christoph Beglinger (2) , Bettina Wölnerhanssen (2) , Ralph Peterli (1) 1. Department of Surgery, St. Claraspital AG, Kleinriehenstrasse 30, CH-4058 Basel, Switzerland 2. Clinical Trial Unit, St. Claraspital AG, Kleinriehenstrasse 30, CH-4058 Basel, Switzerland | |
| S3 | Laparoscopic Versus Open Intraperitoneal Onlay Mesh Incisional Hernia Repair Joël L. Lavanchy(1), Stefan E. Buff(1), Andreas Kohler(1), Daniel Candinas(1), Guido Beldi(1) (1) Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland | |
| S4 | Outcomes of 66 consecutive transanal total mesorectal excisions for low rectal cancer Rebekka Troller, Felix Grieder, Hans Gelpke, David Schulthess, Stefan Breitenstein, Michel Adamina Department of Visceral and Thoracic Surgery, Cantonal Hospital of Winterthur, Winterthur, Switzerland | |
| S5 | Incidence and prognosis of lymph node metastasis in patients with limb soft tissue sarcoma François Crettenand (1), David Martin (2), Stéphane Cherix (3), Nicolas Demartines (2), Maurice Matter (2) (1) Department of Urology, University Hospital CHUV, Lausanne (2) Department of Visceral Surgery, University Hospital CHUV, Lausanne (3) Department of Orthopedics and Traumatology, University Hospital CHUV, Lausanne | |
| S6 | The purinergic receptor P2X1 is required during immune mediated liver injury Daniel Spari(1), Manuel Jakob(1), Adrian Keogh(1), Deborah Stroka(1), Daniel Candinas(1), Guido Beldi(1) (1)Department for Visceral Surgery and Medicine, Bern University Hospital, University of Bern, Bern, Switzerland | |
| S7 | Pure laparoscopic liver hanging maneuver for right hepatectomy – a video Fariba Abbassi (1,3), Roxanne M. Villiger (2), Peter Villiger (3) 1 Department of Visceral Surgery, Geneva University Hospitals, Geneva 2 Faculty of Medecine, University of Zurich, Zurich 3 Department of Visceral Surgery, Cantonal Hospital of Grisons, Chur | |
| S8 | Bacterial Translocation impairs Liver Regeneration after two third Partial Hepatectomy Manuel Jakob(1), Mercedes Gomez de Agüero(2), Daniel Spari(1), Deborah Stroka(1), Daniel Candinas(1), Guido Beldi(1) (1)Department for Visceral Surgery and Medicine, Bern University Hospital, University of Bern, Bern, Switzerland; (2)Department of Gastroenterology/Mucosal Immunology, Bern University Hospital, University of Bern, Bern, Switzerland | |
| S9 | Porcine islets of Langerhans: Multifocal transplantation might improve transplantation outcomes Stefan H. Schlosser 1, 2 Vasiliy Moskalenko 2 Karin Ulrichs 2 Alexander Kerscher 2 1 Department of Gastroenterology, Clinic for Visceral Surgery and Medicine, University Hospital of Bern, Switzerland 2 Experimental Transplantation Immunology, Department of General, Visceral, Vascular and Paediatric Surgery (Surgical Clinic I), University Hospital of Würzburg, Germany | |
| S10 | Immunosuppression and Echinococcus multilocularis
infection: The influence of a weakened immunostatus on
disease incidence Daniel Spari(1), Anja Lachenmayer(2), David Gebbers(2), Daniel Candinas(2), Bruno Gottstein(3), Guido Beldi(1,2) (1)Department of Clinical Research, Visceral and Transplantation Surgery, Murtenstrasse 35, Bern, Switzerland; (2)Department of Visceral Surgery and Medicine, University Hospital of Bern, Switzerland; (3)Institute of Parasitology, Veterinary Medicine, University Hospital of Bern, Switzerland | |
| S11 | Tight Cell Junction Control of Liver Regeneration Felix Baier, Giulio Loforese, Ramesh Kudira, Fadi Jebbawi, Daniel Candinas, Guido Beldi, Deborah Stroka Visceral Surgery Research Laboratory, Department of Clinical Research, Inselspital and University of Bern | |
| S12 | LIM Protein Ajuba Promotes Cancer Cell Proliferation and Survival in Hepatocellular Carcinoma Noëlle Dommann (1), Jacopo Gavini (1), Giulio Loforese (1), Felix Baier (1), Daniel Candinas (1), Deborah Stroka (1) (1) Visceral Surgery and medicine, Department of Clinical Research Bern, Switzerland | |
| S13 | Direct and indirect hepatoprotective mechanism of CBLB502 a TLR5 Agonist Nicolas Melin(1), René Fahrner(1,2), Adrian Keogh(1), Michaela Medova(1), Yitzhak Zimmer(1), Daniel Aebersold(1), Guido Beldi(1), Daniel Candinas(1), Deborah Stroka(1) (1) Inselspital, universität Bern, Switzerland (2) Universitätsklinikum Jena, Germany | |
| S14 | Intraabdominal hypertension leads to systemic ATP release Michel Dosch(1), Anina Vinzens(1), Andreas Kohler(1), Andreas Bloch(2), Stephan Jakob(2), Daniel Candinas(1), Guido Beldi(1). (1) Department of Clinical Research, Visceral Surgery and Medicine, University of Bern (2) Department of Intensive Care Medicine, University Hospital of Bern | |
| S15 | Macrophages regulate outcome of sepsis via connexin 43 dependent ATP release Michel Dosch(1), Deborah Stroka(1), Daniel Candinas(1), Guido Beldi(1). (1) Department of Clinical Research, Visceral Surgery Research Laboratory, University of Bern | |
| S16 | Is there a role for surgery for neuroendocrine tumors of the esophagus – a contemporary view from NCDB Suna Erdem(1), Esther Troxler(1), René Warschkow(2), Babatunde Yerokun(3), Matthew Hartwig(3), Bruno Schmied(2), Christian A. Seiler(1), Beat Gloor(1), Mathias Worni(1) (1)Department of Visceral Surgery and Medicine, Inselspital, Bern; (2)Department of Surgery Kantonsspital St. Gallen; (3)Duke University Medical Center, Durham, NC, USA | |
| S17 | Checkpoint blockade modulates the immune response in hepatic Alveolar echinococcosis infection Fadi Jebbawi(1), Junhua Wang(2), Daniel Candinas(1), Bruno Gottstein(2), Guido Beldi(1) Author information 1- Department of Visceral transplantation and surgery, Inselspital, University of Bern, Bern, Switzerland 2- Department of infectious Diseases and Pathobiology, Institute of Parasitology, University of Bern, Bern, Switzerland | |
| S18 | Percutaneous image-guided stereotactic microwave ablation (PISMA) for non-colorectal liver metastases Stéphanie Perrodin, MD, Anja Lachenmayer, MD, Pascale Tinguely, MD, Prof. Guido Beldi, MD, Prof. Daniel Candinas, MD, Vanessa Banz, MD PhD Department for Visceral Surgery and Medicine, Inselspital, Bern University Hospital and University of Bern, Switzerland | |
| S19 | First experience of robotic-assisted (da Vinci Xi) surgery for giant hiatal hernias and comparison to laparoscopy Alexander Wilhelm, Fiorenzo V Angehrn, Romano Schneider, Luca Koechlin, Diana L Daume, Markus von Flüe, Martin Bolli Department of Surgery, Hospital St. Clara, Basel, Switzerland | |